Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Clinical Immunosuppression Kidney early
15 August 2010  /  00:01 - 00:01

Impact of Sirolimus and Calcineurin Inhibitors on Carotis Intima-Media Thickness and Atherosclerotic Plaque Formation in Renal Transplant Patients: A Prospective Study

Presenter: Julide Sagiroglu, Fulya, Sisli, Turkey

- Impact of Sirolimus and Calcineurin Inhibitors on Carotis Intima-Media Thickness and Atherosclerotic Plaque Formation in Renal Transplant Patients: A Prospective Study

Presenter: Julide Sagiroglu, Fulya, Sisli, Turkey

A clinical study comparing Azathioprine and Mycophenolate mofetil after IL2 receptor antibody induction in live related kidney transplantation

Presenter: sandip bhattacharya, kolkata, India

- A clinical study comparing Azathioprine and Mycophenolate mofetil after IL2 receptor antibody induction in live related kidney transplantation

Presenter: sandip bhattacharya, kolkata, India

Dose Related Incidences of Wound Healing Events in Renal Transplant Recipients Treated With Everolimus and Cyclosporine

Presenter: Anantharaman Vathsala, Singapore, Singapore

- Dose Related Incidences of Wound Healing Events in Renal Transplant Recipients Treated With Everolimus and Cyclosporine

Presenter: Anantharaman Vathsala, Singapore, Singapore

Clinical Outcomes of Kidney Transplant Recipients during Transition from Immunoassay to Tandem Mass Spectrometry based Therapeutic Drug Monitoring of Everolimus

Presenter: Petrina Yuen Wai Fan, Singapore, Singapore

- Clinical Outcomes of Kidney Transplant Recipients during Transition from Immunoassay to Tandem Mass Spectrometry based Therapeutic Drug Monitoring of Everolimus

Presenter: Petrina Yuen Wai Fan, Singapore, Singapore

Variations in CYP3A4, CYP3A5 and MDR1 have an impact on gene transcription and activity: importance in CNI metabolism

Presenter: Nirupama Chandel, Chandigarh, India

- Variations in CYP3A4, CYP3A5 and MDR1 have an impact on gene transcription and activity: importance in CNI metabolism

Presenter: Nirupama Chandel, Chandigarh, India

Tolerance of EC-MPS in combination with CNI in kidney transplant recipients - polish experience.

Presenter: Jolanta Gozdowska, Warsaw, Poland

- Tolerance of EC-MPS in combination with CNI in kidney transplant recipients - polish experience.

Presenter: Jolanta Gozdowska, Warsaw, Poland

Raltegravir and enfuvirtide as a "bridge" antiretroviral therapy in kidney-transplanted patients with hiv infection receiving an everolimus-based regimen: a study on outcomes and drug interactions.

Presenter: Vittorio Albertazzi, Modena, Italy

- Raltegravir and enfuvirtide as a "bridge" antiretroviral therapy in kidney-transplanted patients with hiv infection receiving an everolimus-based regimen: a study on outcomes and drug interactions.

Presenter: Vittorio Albertazzi, Modena, Italy

Clinical pharmacokinetics of tacrolimus in renal transplant patients and determination of best sampling time for correlation with drug exposure

Presenter: PILAR SALVADOR, A CORUÑA, Spain

- Clinical pharmacokinetics of tacrolimus in renal transplant patients and determination of best sampling time for correlation with drug exposure

Presenter: PILAR SALVADOR, A CORUÑA, Spain

Routine reduction in mycophenolate mofetil from 1g twice daily to 0.5g twice daily after the first 30 days does not compromise short term outcome.

Presenter: Andrew Watts, London,

- Routine reduction in mycophenolate mofetil from 1g twice daily to 0.5g twice daily after the first 30 days does not compromise short term outcome.

Presenter: Andrew Watts, London,

Neither mycophenolate acyl-glucuronide (AcMPAG) levels nor their AUC is responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA

Presenter: Matthias Raggi, Stuttgart, Germany

- Neither mycophenolate acyl-glucuronide (AcMPAG) levels nor their AUC is responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA

Presenter: Matthias Raggi, Stuttgart, Germany

Population pharmacokinetics of mycophenolic acid: a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

Presenter: MARIA OUTEDA, A CORUÑA, Spain

- Population pharmacokinetics of mycophenolic acid: a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

Presenter: MARIA OUTEDA, A CORUÑA, Spain

Advantages of basiliximab induction combined with modern immunosuppressive drugs.

Presenter: Helio Tedesco Silva, Sao Paulo, Brazil

- Advantages of basiliximab induction combined with modern immunosuppressive drugs.

Presenter: Helio Tedesco Silva, Sao Paulo, Brazil

Genetic polymorphisms and formulation differences on the severity of gastrointestinal side effects in kidney allograft recipients

Presenter: Eglis Tellez-Corrales, , Afghanistan

- Genetic polymorphisms and formulation differences on the severity of gastrointestinal side effects in kidney allograft recipients

Presenter: Eglis Tellez-Corrales, , Afghanistan

Role Of Azathiaprine As Maintenance Immunosuppressive Agent In Kidney Transplantation The Indian Scenario

Presenter: V Kher, GURGAON, India

- Role Of Azathiaprine As Maintenance Immunosuppressive Agent In Kidney Transplantation The Indian Scenario

Presenter: V Kher, GURGAON, India

A Combined Polyclonal/Monoclonal Induction Strategy: Superior Results in High Risk Renal Transplantation

Presenter: Helmut Arbogast, Munich, Germany

- A Combined Polyclonal/Monoclonal Induction Strategy: Superior Results in High Risk Renal Transplantation

Presenter: Helmut Arbogast, Munich, Germany

Usefulness of Frequent Tacrolimus Level Estimations as Judged by Outcomes in Renal Transplantation

Presenter: K.S. Ramalingam, Coimbatore, India

- Usefulness of Frequent Tacrolimus Level Estimations as Judged by Outcomes in Renal Transplantation

Presenter: K.S. Ramalingam, Coimbatore, India

Immunosuppressants induced changes in micro- and macrocirculation: A prospective study in healthy subjects and patients after kidney transplantation using intravital microscopy, oxygen spectroscopy and colour-coded ultrasound

Presenter: Johannes Hoffmann, Munich, Germany

- Immunosuppressants induced changes in micro- and macrocirculation: A prospective study in healthy subjects and patients after kidney transplantation using intravital microscopy, oxygen spectroscopy and colour-coded ultrasound

Presenter: Johannes Hoffmann, Munich, Germany

Induction Immunosuppression
15 August 2010  /  00:01 - 00:02

Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy Results in Prolonged Selective CD4 T Cell Depletion Irrespective of Maintenance Immunosuppression

Presenter: Oleh Pankewycz, BUFFALO, United States

- Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy Results in Prolonged Selective CD4 T Cell Depletion Irrespective of Maintenance Immunosuppression

Presenter: Oleh Pankewycz, BUFFALO, United States

Low dose ATG induction for older kidney transplant recipients (old for old); single centre experience over 4 years.

Presenter: Martin Nitschke, Lübeck, Germany

- Low dose ATG induction for older kidney transplant recipients (old for old); single centre experience over 4 years.

Presenter: Martin Nitschke, Lübeck, Germany

Low dose rabbit anti-thymocyte globulin induction in low risk renal transplant recipients: 8 years follow up.

Presenter: Mark Reza Laftavi, Buffalo, United States

- Low dose rabbit anti-thymocyte globulin induction in low risk renal transplant recipients: 8 years follow up.

Presenter: Mark Reza Laftavi, Buffalo, United States

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi